Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing ...
Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin ...
Massachusetts robotics entrepreneurs focus on specialized machines, while West Coast companies pour billions into humanoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback